Michelle L. McGowan co-directs the Biomedical Ethics Research Program at Mayo Clinic in Rochester, Minnesota where she is a Professor of Biomedical Ethics in the Mayo Clinic College of Medicine and Sciences. Dr. McGowan is an empirical bioethicist whose research explores ethical and social implications of emerging health technologies and policies. Combining a range of qualitative and normative methods, her empirically informed approach to bioethics scholarship focuses on addressing the uneven distribution of benefits and burdens of associated with the uptake of technologies in healthcare and biomedical research. She is currently a principal investigator of a multiple-PI National Human Genome Research Institute-funded hybrid clinical trial focused on adolescent decision-making in relation to prospective genomic screening. She has also conducted research on the implications of reproductive health policies for genetics professionals, ethical implications the expansion of reproductive genetic and genomic screening and diagnosis, the rhetoric of personalized and precision medicine, and end-users' perspectives on direct-to-consumer personal genome testing. In addition to this research, Dr. McGowan has served as an ethics consultant for the American College of Obstetricians and Gynecologists, the Society for Maternal Fetal Medicine, and the National Society of Genetic Counselors.